Skip to main content

Psychemedics Corp

PMDDelisted Dec 13, 2024
Industry
Services-Medical Laboratories
SEC CIK
0000806517

Psychemedics Corp was delisted on Dec 13, 2024; its insiders filed their last Form 4 on Dec 17, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $2.85M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Psychemedics Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Psychemedics Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Psychemedics Corp
NameTitleLast reported holdingLast filingFilings, past year
Powell Anderson Capital LP10% Owner614,406IndirectDec 17, 20240
PACP Jupiter LLC10% Owner614,406IndirectDec 17, 20240
Powell Anderson Capital Partners LLC10% Owner614,406IndirectDec 17, 20240
Lindsay Richard Adam10% Owner614,406IndirectDec 17, 20240
Kamin PeterDirector, 10% Owner1,499,710IndirectDec 12, 20240
Mehalik DaniellaVice President - Finance–Jan 24, 20240
Shoemaker ShannonChief Revenue Officer–Sep 25, 20230
Weisenhoff MichaelOther: Assistant Controller4,000Aug 22, 20230
Nevin Darius GDirector, Other: See Footnote 123,000Aug 21, 20230
Reynolds AndrewDirector28,000Aug 21, 20230
Davis Robyn CDirector39,000Aug 21, 20230
Doucot Charles MExecutive Vice President23,250Aug 21, 20230
Hullinger BrianPresident & CEO–Aug 21, 20230
Kubacki Raymond C JrChairman, CEO & President246,737May 24, 20230
Schaffer Michael IVP of Laboratory Operations36,489May 24, 20230
Weinert Fred JDirector71,583May 24, 20220
Tomenson Walter SDirector74,399May 24, 20220
Limbek AndrewVice President & Controller13,863May 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 17, 2024 (view filing)8:29 PM ETDec 13-174 daysPowell Anderson Capital LP and 3 others10% OwnerPPurchase+159.7K$1.91+$305.4K+35.1%614.4K after5 lots
Dec 12, 2024 (view filing)8:41 PM ETDec 10-122 daysPowell Anderson Capital LP and 3 others10% OwnerPPurchase+87.0K$2.67+$231.8K+21.3%494.6K after3 lots
Dec 12, 2024 (view filing)Dec 102 daysKamin PeterDirector, 10% OwnerSSaleCommon Stock, $0.005 Par Value−320.7K$2.35−$753.7K−17.6%1.50M after
Dec 5, 2024 (view filing)Dec 32 daysKamin PeterDirector, 10% OwnerPPurchaseCommon Stock, $0.005 Par Value+1.41M$2.35+$3.31M+343.2%1.82M after
Aug 21, 2023 (view filing)Aug 174 daysDoucot Charles MExecutive Vice PresidentSSaleCommon Stock, $.005 Par Value−12.7K$4.66−$59.2K−35.3%23.3K after
Dec 20, 2022 (view filing)Dec 164 daysSchaffer Michael IVP of Laboratory OperationsPPurchaseCommon Stock, $.005 Par Value+100$4.95+$495+0.3%37.2K after
Apr 21, 2022 (view filing)Apr 19-202 daysKamin Peter10% OwnerPPurchase+35.0K$6.56+$230.0K+352.7%45.0K after6 lots
Apr 21, 2022 (view filing)Apr 201 dayKamin Peter10% OwnerPPurchase+8.10K$6.72+$54.4K+3.9%214.0K after
Apr 11, 2022 (view filing)Apr 7-84 daysKamin Peter10% OwnerPPurchase+7.00K$6.74+$47.2K+3.5%205.1K after2 lots
Mar 31, 2022 (view filing)Mar 30-311 dayKamin Peter10% OwnerPPurchase+12.4K$6.89+$85.5K+10.7%128.0K afterAmended2 lots